WallStreetZenWallStreetZen

NASDAQ: PHAR
Pharming Group Nv Earnings & Revenue

PHAR past revenue growth

How has PHAR's revenue growth performed historically?
Company
28.19%
Industry
84.7%
Market
19.99%
PHAR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PHAR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PHAR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PHAR earnings and revenue history

Current Revenue
$280.8M
Current Earnings
-$11.7M
Current Profit Margin
-4.2%

PHAR Return on Equity

Current Company
-5.2%
Current Industry
16.9%
Current Market
28.2%
PHAR's Return on Equity (-5.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PHAR announces earnings.

PHAR Return on Assets

Current Company
-2.4%
Current Industry
3.2%
PHAR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PHAR Return on Capital Employed

Current Company
-5.1%
Current Industry
-42.5%
PHAR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PHAR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PHAR$277.81M$8.15M-$11.60M+57.08%N/A
MNMD$0.00-$122.00M-$125.32MN/AN/A
REPL$0.00-$206.07M-$215.79MN/AN/A
THRD$0.00-$28.88M-$29.60MN/AN/A
PEPG$0.00-$78.88M-$80.33MN/AN/A

PHAR earnings dates

Next earnings date
Aug 1, 2024

Pharming Group Nv Earnings & Revenue FAQ

What were PHAR's earnings last quarter?

On Invalid Date, Pharming Group Nv (NASDAQ: PHAR) reported Q1 2024 earnings per share (EPS) of -$0.21, up 0% year over year. Total Pharming Group Nv earnings for the quarter were -$13.53 million. In the same quarter last year, Pharming Group Nv's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Pharming Group Nv stock.

What was PHAR's earnings growth in the past year?

As of Q2 2024, Pharming Group Nv's earnings has grown year over year. Pharming Group Nv's earnings in the past year totalled -$11.60 million.

What is PHAR's earnings date?

Pharming Group Nv's earnings date is Invalid Date. Add PHAR to your watchlist to be reminded of PHAR's next earnings announcement.

What was PHAR's revenue last quarter?

On Invalid Date, Pharming Group Nv (NASDAQ: PHAR) reported Q1 2024 revenue of $60.42 million up 30.66% year over year. In the same quarter last year, Pharming Group Nv's revenue was $46.24 million.

What was PHAR's revenue growth in the past year?

As of Q2 2024, Pharming Group Nv's revenue has grown 28.19% year over year. This is 56.51 percentage points lower than the US Biotechnology industry revenue growth rate of 84.7%. Pharming Group Nv's revenue in the past year totalled $277.81 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.